Edwards Lifesciences Corporation (EW) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
70/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseEW / S&P 12.96% / 15.20% |
LoseEW / S&P 14.55% / 15.00% |
LoseEW / S&P -75.07% / 50.40% |
| 2026-Q11/3 |
LoseEW / S&P -6.06% / -4.33% |
WinEW / S&P 14.15% / 11.30% |
LoseEW / S&P -73.26% / 27.70% |
| 2025-Q42/3 |
WinEW / S&P 9.62% / 2.65% |
WinEW / S&P 11.55% / 9.00% |
LoseEW / S&P -73.86% / 13.40% |
| 2025-Q31/3 |
LoseEW / S&P -0.56% / 8.12% |
WinEW / S&P 10.60% / 4.61% |
LoseEW / S&P -66.09% / 13.45% |
| 2025-Q22/3 |
LoseEW / S&P 7.91% / 10.94% |
WinEW / S&P 9.14% / 4.83% |
WinEW / S&P 187.24% / 10.63% |
| 2025-Q13/3 |
WinEW / S&P -2.09% / -4.27% |
WinEW / S&P 7.54% / 4.98% |
WinEW / S&P 203.02% / 10.57% |
| 2024-Q42/3 |
WinEW / S&P 12.18% / 2.41% |
LoseEW / S&P 3.32% / 5.25% |
WinEW / S&P 204.35% / 6.15% |
| 2024-Q32/3 |
LoseEW / S&P -28.56% / 5.89% |
WinEW / S&P 20.14% / 5.89% |
WinEW / S&P 196.15% / 6.11% |
| 2024-Q22/3 |
LoseEW / S&P -3.34% / 4.28% |
WinEW / S&P 15.65% / 5.38% |
WinEW / S&P 7.52% / 5.12% |
| 2024-Q12/3 |
WinEW / S&P 25.32% / 10.56% |
WinEW / S&P 12.06% / 5.71% |
LoseEW / S&P -3.73% / 5.59% |
| 2023-Q41/3 |
LoseEW / S&P 10.06% / 11.69% |
WinEW / S&P 17.94% / 6.81% |
LoseEW / S&P -5.74% / 7.78% |
| 2023-Q31/3 |
LoseEW / S&P -26.56% / -3.27% |
LoseEW / S&P -17.44% / 7.52% |
WinEW / S&P 0.86% / -5.03% |
| 2023-Q22/3 |
WinEW / S&P 14.02% / 8.74% |
LoseEW / S&P -15.89% / 9.50% |
WinEW / S&P -2.16% / -8.57% |
| 2023-Q12/3 |
WinEW / S&P 10.88% / 7.50% |
LoseEW / S&P -14.46% / 10.77% |
WinEW / S&P -1.23% / -15.69% |
| 2022-Q41/3 |
LoseEW / S&P -9.71% / 7.56% |
LoseEW / S&P -14.69% / 11.88% |
WinEW / S&P 2.09% / -17.99% |
| 2022-Q31/3 |
LoseEW / S&P -13.10% / -4.88% |
LoseEW / S&P 5.29% / 13.47% |
WinEW / S&P -0.85% / -1.41% |
| 2022-Q20/3 |
LoseEW / S&P -19.22% / -16.10% |
LoseEW / S&P 8.73% / 13.71% |
LoseEW / S&P -0.43% / 11.04% |
| 2022-Q12/3 |
LoseEW / S&P -9.13% / -4.60% |
WinEW / S&P 19.73% / 15.97% |
WinEW / S&P 82.09% / 42.23% |
| 2021-Q42/3 |
WinEW / S&P 14.43% / 11.03% |
WinEW / S&P 19.29% / 15.00% |
LoseEW / S&P 85.27% / 96.40% |
| 2021-Q33/3 |
WinEW / S&P 9.31% / 0.58% |
WinEW / S&P 16.61% / 10.77% |
WinEW / S&P 87.20% / 69.42% |
| 2021-Q23/3 |
WinEW / S&P 23.83% / 8.55% |
WinEW / S&P 13.96% / 6.58% |
WinEW / S&P 100.00% / 51.81% |
| 2021-Q11/3 |
LoseEW / S&P -8.32% / 6.17% |
WinEW / S&P -0.21% / -1.06% |
LoseEW / S&P -22.99% / 7.39% |
| 2020-Q42/3 |
WinEW / S&P 14.29% / 12.15% |
WinEW / S&P 0.88% / -3.72% |
LoseEW / S&P -46.91% / -33.42% |
| 2020-Q32/3 |
WinEW / S&P 15.50% / 8.93% |
WinEW / S&P 5.23% / -2.04% |
LoseEW / S&P -668.18% / -27.10% |
| 2020-Q22/3 |
LoseEW / S&P 9.92% / 20.54% |
WinEW / S&P 9.02% / -0.46% |
WinEW / S&P 182.93% / -27.11% |
| 2020-Q13/3 |
WinEW / S&P -19.15% / -19.60% |
WinEW / S&P 17.34% / 3.47% |
WinEW / S&P 28.89% / -14.75% |
| 2019-Q42/3 |
LoseEW / S&P 6.08% / 9.07% |
WinEW / S&P 16.79% / 5.36% |
WinEW / S&P 115.04% / 2.99% |
| 2019-Q32/3 |
WinEW / S&P 19.04% / 1.70% |
WinEW / S&P 14.26% / 5.02% |
LoseEW / S&P -106.61% / 0.21% |
| 2019-Q21/3 |
LoseEW / S&P -3.44% / 4.30% |
WinEW / S&P 11.71% / 6.64% |
LoseEW / S&P -86.60% / 8.65% |
| 2019-Q12/3 |
WinEW / S&P 24.91% / 13.65% |
WinEW / S&P 10.86% / 8.12% |
LoseEW / S&P -48.08% / 14.29% |
| 2018-Q41/3 |
WinEW / S&P -12.02% / -13.52% |
LoseEW / S&P 8.37% / 9.05% |
LoseEW / S&P -58.15% / 18.23% |
| 2018-Q31/3 |
WinEW / S&P 19.60% / 7.71% |
LoseEW / S&P 9.63% / 10.21% |
LoseEW / S&P -2.92% / 19.06% |
| 2018-Q22/3 |
WinEW / S&P 4.34% / 3.43% |
WinEW / S&P 9.78% / 9.03% |
LoseEW / S&P -6.99% / 14.46% |
| 2018-Q12/3 |
WinEW / S&P 23.79% / -0.76% |
WinEW / S&P 9.42% / 7.68% |
LoseEW / S&P -13.62% / 12.46% |
| 2017-Q41/3 |
LoseEW / S&P 3.11% / 6.64% |
WinEW / S&P 15.91% / 7.03% |
LoseEW / S&P 3.45% / 13.82% |
| 2017-Q32/3 |
LoseEW / S&P -7.55% / 4.48% |
WinEW / S&P 15.60% / 5.68% |
WinEW / S&P 35.57% / 17.57% |
| 2017-Q23/3 |
WinEW / S&P 25.69% / 3.09% |
WinEW / S&P 17.83% / 4.83% |
WinEW / S&P 35.95% / 17.74% |
| 2017-Q12/3 |
LoseEW / S&P 0.39% / 6.07% |
WinEW / S&P 21.12% / 3.67% |
WinEW / S&P 28.09% / 13.32% |
| 2016-Q42/3 |
LoseEW / S&P -22.28% / 3.82% |
WinEW / S&P 18.85% / 2.09% |
WinEW / S&P 16.00% / 7.05% |
| 2016-Q32/3 |
WinEW / S&P 20.89% / 3.85% |
WinEW / S&P 17.48% / 0.20% |
LoseEW / S&P -321.93% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | EW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 10.59% | 20.78% |
| Annualized return | 10.59% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | EW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -24.68% | 83.14% |
| Annualized return | -5.51% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | EW total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 132.89% | 319.30% |
| Annualized return | 8.82% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |